Key facts
- BluePill’s last known valuation is $23.5M (Oct 2025).
- It has raised $6.0M; the latest was Seed Round ($6.0M) in Oct 2025.
- Notable investors include David Spector, David Wickwire, Flying Fish Partners, Pioneer Square Labs, Rotem Hershko — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for BluePill
- ·The full record, as it builds
Funding rounds
No funding rounds for BluePill are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BluePill
Developer of an AI-powered customer analytics platform designed to support data-driven marketing strategy and reduce go-to-market risk. The company's platform enables simulation of customer behavior, generation of predictive insights, and analysis of potential campaign outcomes, enabling marketing teams and product managers to evaluate strategies, optimize decision-making, and improve campaign effectiveness before launch.
- Sector
- Information Technology
- HQ
- Seattle, WA, United States
- Founded
- 2025
- Employees
- 5
- Website
- blue-pill.ai/
- Ownership
- Privately Held (backing)
BluePill doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BluePill shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BluePill in its N-PORT filings yet. We sweep new filings monthly.